paraquat has been researched along with Parkinson Disease, Secondary in 65 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (9.23) | 18.7374 |
1990's | 1 (1.54) | 18.2507 |
2000's | 17 (26.15) | 29.6817 |
2010's | 35 (53.85) | 24.3611 |
2020's | 6 (9.23) | 2.80 |
Authors | Studies |
---|---|
Dorsey, ER; Ray, A | 1 |
Chtarbanova, S; Maitra, U; O'Donnell, JM; Scaglione, MN | 1 |
Afiyatullov, SS; Antonov, AS; Chingizova, EA; Dyshlovoy, SA; Girich Ivanets, EV; Kim, NY; Menchinskaya, ES; Pislyagin, EA; Smetanina, OF; Trinh, PTH; Van, TTT; von Amsberg, G; Yurchenko, AN; Yurchenko, EA | 1 |
Jiang, E; Li, F; Pang, H; Wen, G; Wu, X; Zhan, X | 1 |
Chen, RJ; Day, CH; Ho, TJ; Huang, CY; Ju, DT; Kuo, WW; Liao, PH; Shibu, MA; Sivalingam, K; Viswanadha, VP | 1 |
Ahmad, B; Akhtar, MF; Anwar, F; Ismail, T; Nazir, S; Saleem, U; Sanawar, M | 1 |
Buechner, S; Dassati, S; Schweigreiter, R; Waldner, A | 1 |
Weed, DL | 1 |
de Camargo, JLV; El Dib, R; Vaccari, C | 1 |
Anselmi, L; Bove, C; Hampton, J; Toti, L; Travagli, RA | 1 |
Che, Y; Hou, L; Li, H; Sun, F; Wang, K; Wang, Q; Zhang, C; Zhang, D; Zhao, X | 1 |
Che, Y; Hou, L; Sun, F; Wang, Q | 1 |
Che, Y; Hou, L; Li, H; Liu, X; Piao, F; Sun, F; Wang, Q; Zhang, C; Zhang, D | 1 |
Li, H; Wang, L; Wang, Q; Wang, Z; Wu, S; Yang, H; Zhang, Q | 1 |
S, N; Shivanandappa, T | 1 |
Adeluwa, TP; Akinyede, AA; Ishola, IO; Micah, C | 1 |
Emmerson, JT; Hayley, S; Jadavji, NM; Murray, LK; Rudyk, CA; Smith, PD | 1 |
Jimenez-Del-Rio, M; Ortega-Arellano, HF; Velez-Pardo, C | 1 |
Lenaers, G; Reynier, P; Thany, SH | 1 |
Dixit, A; Mishra, M; Prakash, O; Singh, MP; Singh, PK; Srivastava, G; Verma, D | 1 |
Kamel, F | 1 |
Cloutier, M; Finnerty, NJ; Lowry, JP; O'Riordan, SL; Wellstead, P | 1 |
Baltazar, MT; Carvalho, F; de Lourdes Bastos, M; Dinis-Oliveira, RJ; Duarte, JA; Tsatsakis, AM | 1 |
Abdin, MZ; Chaouhan, HS; Kar Chowdhuri, D; Patel, DK; Pragya, P; Shukla, AK | 1 |
Assani, K; Barajas, A; Krantz, DE; Lawal, HO; Lawless, G; Lumintang, YP; Martin, CA; Nunez, V | 1 |
Candeletti, S; Caputi, FF; Carretta, D; Lattanzio, F; Palmisano, M; Romualdi, P | 1 |
Thompson, M; Xu, YH; Zhang, XF | 1 |
Rai, SN; Singh, SP; Yadav, SK | 1 |
Fujioka, H; Siedlak, SL; Tang, B; Wang, C; Wang, W; Zhao, F; Zhu, X | 1 |
Dhanasekaran, M; Karuppagounder, SS; Suppiramaniam, V; Thrash, B; Uthayathas, S | 1 |
Borowy-Borowski, H; Cohen, J; Matei, A; Pandey, S; Sandhu, JK; Sikorska, M; Somayajulu-Niţu, M; Sridhar, TS | 1 |
Cicchetti, F; Drouin-Ouellet, J; Gross, RE | 1 |
Hayley, S; Litteljohn, D; Mangano, E; Shukla, N | 1 |
Gupta, SP; Patel, S; Singh, AK; Singh, MP; Singh, S; Yadav, S | 1 |
Burns, M; Franco, R; Li, S; Panayiotidis, MI; Rodriguez-Rocha, H | 1 |
Cannon, JR; Greenamyre, JT | 1 |
Bronstein, J; Cockburn, M; Costello, S; Ritz, B; Wang, A; Zhang, X | 1 |
Spivey, A | 1 |
Bové, J; Perier, C | 1 |
Gupta, SP; Singh, MP; Srivastava, G; Srivastava, PK; Yadav, S | 1 |
Tieu, K | 1 |
Armentero, MT; Blandini, F | 1 |
Beal, MF; Calingasan, NY; Elemento, O; Gollamudi, S; Johri, A; Yang, L | 1 |
Bhudhikanok, GS; Blair, A; Chade, AR; Comyns, K; Goldman, SM; Hoppin, JA; Kamel, F; Kasten, M; Korell, M; Langston, JW; Marras, C; Meng, C; Richards, MB; Ross, GW; Sandler, DP; Tanner, CM; Umbach, DM | 1 |
Colosio, C; Moretto, A | 1 |
Cory-Slechta, DA; Di Monte, DA; Langston, JW; Manning-Bog, AB; McCormack, AL; Thiffault, C; Thiruchelvam, M | 1 |
Di Monte, DA; McCormack, AL | 1 |
Baggs, RB; Cory-Slechta, DA; Di Monte, DA; McCormack, A; Richfield, EK; Tank, AW; Thiruchelvam, M | 1 |
Andersen, JK | 1 |
Cheng, CM; Li, X; Li, Z; Sun, JL; Wu, YL; Yin, J | 1 |
Bortel, A; Dabrowska, J; Kuter, K; Kwieciński, A; Lenda, T; Nowak, P; Ossowska, K; Smiałowska, M; Wardas, J; Wierońska, JM; Wolfarth, S; Zieba, B | 1 |
Kadota, S; Li, X; Matsumoto, K; Murakami, Y; Tezuka, Y; Wu, Y | 1 |
Bové, J; Perier, C; Prou, D; Przedborski, S | 1 |
Davis, RW; Doostzadeh, J; Giaever, GN; Langston, JW; Nislow, C | 1 |
Bandez, MJ; Gomez, C; Navarro, A | 1 |
Cavada, C; Cuadrado, A; de Sagarra, MR; Rojo, AI | 1 |
Buckley, B; Mirochnitchenko, O; Prasad, K; Richfield, EK; Thiruchelvam, MJ; Winnik, B | 1 |
Brooks, AI; Chadwick, CA; Cory-Slechta, DA; Federoff, HJ; Gelbard, HA | 1 |
Baggs, RB; Cory-Slechta, DA; Richfield, EK; Tank, AW; Thiruchelvam, M | 1 |
Caporali, M; Casali, C; Morocutti, C; Sancesario, G; Stefano, E | 1 |
Fogt, F; von Clarmann, M; Zilker, T | 1 |
Hefti, F; Sanchez-Ramos, JR; Weiner, WJ | 1 |
Rajput, AH; Uitti, RJ | 1 |
Koller, WC | 1 |
Barbeau, A; Buu, NT; Dallaire, L; Poirier, J; Rucinska, E | 1 |
14 review(s) available for paraquat and Parkinson Disease, Secondary
Article | Year |
---|---|
Does paraquat cause Parkinson's disease? A review of reviews.
Topics: Animals; Herbicides; Humans; Meta-Analysis as Topic; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Risk Factors; Systematic Reviews as Topic | 2021 |
Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases--a mechanistic approach.
Topics: Animals; Apoptosis; Dieldrin; Environmental Exposure; Humans; Maneb; Neurodegenerative Diseases; Organophosphates; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Pesticides; Proteasome Inhibitors; Pyrethrins | 2014 |
Multifactorial theory applied to the neurotoxicity of paraquat and paraquat-induced mechanisms of developing Parkinson's disease.
Topics: Animals; Blood-Brain Barrier; Brain; Disease Models, Animal; Dopaminergic Neurons; Electron Transport Complex I; Energy Metabolism; Environmental Pollutants; Herbicides; Humans; Models, Neurological; NADPH Oxidases; Neurotoxins; Nitric Oxide Synthase Type I; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Risk Factors | 2016 |
Paraquat and maneb induced neurotoxicity.
Topics: Animals; Apoptosis; Drug Interactions; Fungicides, Industrial; Herbicides; Humans; Inflammation; Maneb; Mitochondria; Necrosis; Neurotoxicity Syndromes; Oxidative Stress; Paraquat; Parkinson Disease, Secondary | 2007 |
Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
Topics: Animals; Disease Models, Animal; Environmental Exposure; Humans; Maneb; Paraquat; Parkinson Disease, Secondary; Pesticides; Rotenone | 2009 |
Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease.
Topics: Animals; Humans; Neurodegenerative Diseases; Neurons; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Pesticides | 2010 |
Neurotoxic in vivo models of Parkinson's disease recent advances.
Topics: Animals; Disease Models, Animal; Dopamine; Humans; MPTP Poisoning; Neurotoxicity Syndromes; Neurotoxins; Oxidopamine; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Rotenone; Sympatholytics; Uncoupling Agents | 2010 |
Neurotoxin-based models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Cell Death; Disease Models, Animal; Neurotoxins; Oxidopamine; Paraquat; Parkinson Disease, Secondary; Rotenone | 2012 |
A guide to neurotoxic animal models of Parkinson's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Haplorhini; Lewy Bodies; Mice; MPTP Poisoning; Neurotoxins; Oxidopamine; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rotenone; Substantia Nigra | 2011 |
Animal models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Animals, Genetically Modified; Disease Models, Animal; Dopamine Agents; Herbicides; Humans; Neurotoxins; Oxidopamine; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Sympatholytics | 2012 |
The role of pesticide exposure in the genesis of Parkinson's disease: epidemiological studies and experimental data.
Topics: Animals; Animals, Genetically Modified; Disease Models, Animal; Environmental Exposure; Herbicides; Humans; Paraquat; Parkinson Disease, Secondary; Parkinsonian Disorders | 2013 |
Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease.
Topics: Dopamine; Drug Synergism; Environmental Pollutants; Herbicides; Humans; Iron; Nerve Degeneration; Nerve Tissue Proteins; Paraquat; Parkinson Disease, Secondary; Risk Factors; Synucleins | 2003 |
Toxin-induced models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Herbicides; Humans; Neurotoxins; Oxidative Stress; Oxidopamine; Paraquat; Parkinson Disease, Secondary; Rotenone; Sympatholytics | 2005 |
Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome.
Topics: Animals; Free Radicals; Humans; Mitochondria; Nitric Oxide; Paraquat; Parkinson Disease, Secondary; Pesticides; Pyridazines; Rats; Rotenone | 2007 |
51 other study(ies) available for paraquat and Parkinson Disease, Secondary
Article | Year |
---|---|
Paraquat, Parkinson's Disease, and Agnotology.
Topics: Humans; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Pesticides | 2023 |
Innate immune responses to paraquat exposure in a Drosophila model of Parkinson's disease.
Topics: Animals; Drosophila melanogaster; Drosophila Proteins; Gene Expression Profiling; Humans; Immunity, Innate; Paraquat; Parkinson Disease, Secondary; Signal Transduction | 2019 |
Biologically Active Echinulin-Related Indolediketopiperazines from the Marine Sediment-Derived Fungus
Topics: Alkaloids; Aspergillus; Chromatography, High Pressure Liquid; Geologic Sediments; Humans; Neurons; Neuroprotective Agents; Paraquat; Parkinson Disease, Secondary; Piperazine | 2019 |
Secretogranin III upregulation is involved in parkinsonian toxin-mediated astroglia activation.
Topics: Astrocytes; Cell Cycle; Chlorides; Chromogranins; Dopamine; Glial Fibrillary Acidic Protein; Humans; Manganese Compounds; MPTP Poisoning; Neurotoxins; Paraquat; Parkinson Disease, Secondary; Secretogranin II; Tumor Cells, Cultured; Up-Regulation | 2020 |
Induction of Autophagy by Vasicinone Protects Neural Cells from Mitochondrial Dysfunction and Attenuates Paraquat-Mediated Parkinson's Disease Associated α-Synuclein Levels.
Topics: Alkaloids; alpha-Synuclein; Animals; Autophagy; Cells, Cultured; Justicia; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitophagy; Neuroprotective Agents; Paraquat; Parkinson Disease, Secondary; Phytotherapy; Protein Deglycase DJ-1; Protein Kinases; Reactive Oxygen Species; Ubiquitin-Protein Ligases | 2020 |
Investigation of anti-Parkinson activity of dicyclomine.
Topics: Animals; Dicyclomine; Disease Models, Animal; Dopamine; Haloperidol; Mice; Paraquat; Parkinson Disease, Secondary; Parkinsonian Disorders; Substantia Nigra | 2022 |
Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease.
Topics: Apolipoproteins D; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Celecoxib; Cell Line, Tumor; Hippocampus; Humans; Neuroprotection; Oxidopamine; Paraquat; Parkinson Disease, Secondary; Up-Regulation | 2021 |
Paraquat and Parkinson's disease: a systematic review protocol according to the OHAT approach for hazard identification.
Topics: Animals; Dose-Response Relationship, Drug; Environmental Exposure; Humans; Neural Pathways; Observational Studies as Topic; Paraquat; Parkinson Disease, Secondary; Pesticides; Research Design; Review Literature as Topic; Risk Factors; Systematic Reviews as Topic | 2017 |
A Nigro-Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism.
Topics: Animals; Brain Stem; Disease Models, Animal; Gastric Emptying; Immunohistochemistry; Male; Motor Activity; Neural Pathways; Neuroanatomical Tract-Tracing Techniques; Neurotransmitter Agents; Optogenetics; Paraquat; Parkinson Disease, Secondary; Pars Compacta; Rats, Sprague-Dawley; Receptors, Dopamine D1; Stomach; Time Factors; Vagus Nerve | 2017 |
Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway.
Topics: Animals; Cells, Cultured; Dopaminergic Neurons; Enzyme Activation; Macrophage-1 Antigen; MAP Kinase Signaling System; Mice, Inbred C57BL; NADPH Oxidase 2; Paraquat; Parkinson Disease, Secondary; Pesticides; Rats, Sprague-Dawley; Signal Transduction; src-Family Kinases | 2018 |
Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson's disease model by inhibiting microglial M1 polarization.
Topics: Animals; Locus Coeruleus; Male; Maneb; Mice; Microglia; NADPH Oxidases; Neurons; Neuroprotective Agents; Paraquat; Parkinson Disease, Secondary; STAT1 Transcription Factor; STAT3 Transcription Factor; Taurine | 2018 |
Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.
Topics: alpha-Synuclein; Animals; Disease Models, Animal; Dopaminergic Neurons; Gait; Gene Expression; Male; Maneb; Mice; Mice, Inbred C57BL; Microglia; NADPH Oxidase 2; NADPH Oxidases; Neuroprotective Agents; NF-kappa B; Paraquat; Parkinson Disease, Secondary; Signal Transduction; Taurine | 2018 |
Paraquat and MPTP induce alteration in the expression profile of long noncoding RNAs in the substantia nigra of mice: Role of the transcription factor Nrf2.
Topics: Animals; Cell Line; Gene Expression Profiling; Gene Knockdown Techniques; Gene Targeting; Herbicides; Male; Mice; Mice, Inbred ICR; Mice, Knockout; MPTP Poisoning; Neurons; NF-E2-Related Factor 2; Paraquat; Parkinson Disease, Secondary; RNA, Long Noncoding; RNA, Small Interfering; Signal Transduction; Substantia Nigra | 2018 |
Neuroprotective action of 4-Hydroxyisophthalic acid against paraquat-induced motor impairment involves amelioration of mitochondrial damage and neurodegeneration in Drosophila.
Topics: Acetylcholinesterase; Animals; Brain; Disease Models, Animal; Drosophila melanogaster; Female; Herbicides; Male; Mitochondria; Motor Activity; Movement Disorders; Neuroprotective Agents; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Phthalic Acids | 2018 |
Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation.
Topics: Animals; Glutathione; Herbicides; Inflammation; Male; Mice; Motor Activity; Neuroprotective Agents; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Rotarod Performance Test; Superoxide Dismutase; Vinca Alkaloids | 2018 |
Paraquat Exposure Increases Oxidative Stress Within the Dorsal Striatum of Male Mice With a Genetic Deficiency in One-carbon Metabolism.
Topics: Animals; Behavior, Animal; Corpus Striatum; Herbicides; Male; Maze Learning; Methylenetetrahydrofolate Reductase (NADPH2); Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neurons; Oxidative Stress; Paraquat; Parkinson Disease, Secondary | 2019 |
Neuroprotective Effects of Methanolic Extract of Avocado Persea americana (var. Colinred) Peel on Paraquat-Induced Locomotor Impairment, Lipid Peroxidation and Shortage of Life Span in Transgenic knockdown Parkin Drosophila melanogaster.
Topics: Animals; Animals, Genetically Modified; Antioxidants; Drosophila melanogaster; Drosophila Proteins; Fruit; Gene Knockdown Techniques; Lipid Peroxidation; Longevity; Methanol; Neuroprotective Agents; Paraquat; Parkinson Disease, Secondary; Persea; Plant Extracts; Ubiquitin-Protein Ligases | 2019 |
[Neurotoxicity of pesticides: its relationship with neurodegenerative diseases].
Topics: alpha-Synuclein; Alzheimer Disease; Animals; Genetic Predisposition to Disease; Humans; Insecticides; Mitochondria; Neurodegenerative Diseases; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Pesticides; Rotenone | 2013 |
Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Disease Models, Animal; Dopamine; Homeodomain Proteins; Levodopa; Male; Maneb; Metalloporphyrins; Mice; Microglia; Minocycline; Mitochondria; Paraquat; Parkinson Disease, Secondary; Proteome; Stathmin; Superoxide Dismutase | 2013 |
Epidemiology. Paths from pesticides to Parkinson's.
Topics: Amyotrophic Lateral Sclerosis; Animals; Dementia; Environmental Exposure; Humans; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Pesticides; Risk Factors; Rotenone | 2013 |
Continuous real-time in vivo measurement of cerebral nitric oxide supports theoretical predictions of an irreversible switching in cerebral ROS after sufficient exposure to external toxins.
Topics: Animals; Brain Chemistry; Computer Systems; Dose-Response Relationship, Drug; Electrodes, Implanted; Male; Neostriatum; Nitric Oxide; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Rats; Rats, Wistar; Reactive Oxygen Species | 2013 |
Mutation in Drosophila methuselah resists paraquat induced Parkinson-like phenotypes.
Topics: Aging; Animals; Apoptosis; Caspase 3; Dopamine; Dopaminergic Neurons; Drosophila; Drosophila Proteins; Forkhead Transcription Factors; Herbicide Resistance; Herbicides; Male; MAP Kinase Kinase 4; Motor Activity; Mutation; Nerve Degeneration; Neuropeptides; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Phenotype; Receptors, G-Protein-Coupled | 2014 |
Synergistic effects on dopamine cell death in a Drosophila model of chronic toxin exposure.
Topics: Animals; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Drosophila melanogaster; Maneb; Motor Activity; Paraquat; Parkinson Disease, Secondary; Pesticides; Survival Analysis; Ubiquitin-Protein Ligases; Ziram | 2014 |
Proteasome subunit and opioid receptor gene expression down-regulation induced by paraquat and maneb in human neuroblastoma SH-SY5Y cells.
Topics: alpha-Synuclein; ATPases Associated with Diverse Cellular Activities; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Insecticides; Maneb; Models, Biological; Neuroblastoma; Paraquat; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Receptors, Opioid; Tyrosine 3-Monooxygenase | 2015 |
Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model.
Topics: Animals; Behavior, Animal; Corpus Striatum; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mucuna; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Paraquat; Parkinson Disease, Secondary; Plant Extracts; RNA; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |
Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
Topics: Animals; Cell Line, Tumor; Dopaminergic Neurons; GTP Phosphohydrolases; Humans; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Proteins; Nerve Tissue Proteins; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Substantia Nigra | 2017 |
Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.
Topics: Animals; Cell Death; Immunohistochemistry; Locomotion; Male; Mesencephalon; Neurons; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Rats; Rats, Long-Evans; Rotarod Performance Test; Tyrosine 3-Monooxygenase; Ubiquinone; Vitamins | 2009 |
Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat.
Topics: Animals; Behavior, Animal; Brain; Dopamine; Interferon-gamma; Mice; Mice, Knockout; Motor Activity; Paraquat; Parkinson Disease, Secondary; Pesticides | 2009 |
Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?
Topics: Animals; Corpus Striatum; Guanidines; Lipid Peroxidation; Male; Maneb; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Paraquat; Parkinson Disease, Secondary; Pesticides; Phenotype; RNA, Messenger; Second Messenger Systems; Tyrosine 3-Monooxygenase | 2010 |
Parkinson's disease risk from ambient exposure to pesticides.
Topics: Age Factors; California; Environmental Exposure; Female; Geographic Information Systems; Humans; Male; Maneb; Middle Aged; Occupational Exposure; Paraquat; Parkinson Disease, Secondary; Pesticides; Risk Factors; Smoking; Socioeconomic Factors; Ziram | 2011 |
Rotenone and paraquat linked to Parkinson's disease: human exposure study supports years of animal studies.
Topics: Herbicides; Humans; Insecticides; Paraquat; Parkinson Disease, Secondary; Rotenone; United States | 2011 |
Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.
Topics: Animals; Caffeine; Inflammation Mediators; Male; Maneb; Mice; Neuroprotective Agents; Nitric Oxide; Paraquat; Parkinson Disease, Secondary; Phenotype | 2012 |
Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease.
Topics: Animals; Corpus Striatum; Gene Expression Profiling; Gene Regulatory Networks; Humans; Male; Maneb; Mesencephalon; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Pesticides; Pyridazines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcriptome | 2012 |
Genetic modification of the association of paraquat and Parkinson's disease.
Topics: Age Factors; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Diagnosis, Computer-Assisted; Disease Susceptibility; Female; Gene Deletion; Genetic Association Studies; Genotype; Glutathione Transferase; Herbicides; Humans; Male; Middle Aged; Occupational Exposure; Paraquat; Parkinson Disease, Secondary; Risk Factors; Surveys and Questionnaires | 2012 |
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Dopamine; Environmental Exposure; gamma-Aminobutyric Acid; Gliosis; Herbicides; Homovanillic Acid; Humans; Injections, Intraperitoneal; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Paraquat; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase | 2002 |
Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration.
Topics: Amino Acids; Animals; Corpus Striatum; Disease Models, Animal; Levodopa; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Paraquat; Parkinson Disease, Secondary; Substantia Nigra; Tyrosine 3-Monooxygenase | 2003 |
Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.
Topics: Aging; Animals; Cell Count; Corpus Striatum; Disease Susceptibility; Dopamine; Drug Combinations; Glutamate Decarboxylase; Male; Maneb; Mice; Mice, Inbred C57BL; Motor Activity; Neurons; Neurotoxins; Paraquat; Parkinson Disease, Secondary; Phenotype; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase | 2003 |
Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
Topics: Aging; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Paraquat; Parkinson Disease, Secondary; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?
Topics: Algorithms; Animals; Autoradiography; Caudate Nucleus; Dopamine; Herbicides; Male; Neurons; Neurotransmitter Agents; Norepinephrine; Paraquat; Parkinson Disease, Secondary; Piperazines; Putamen; Rats; Rats, Wistar; Serotonin; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2005 |
Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dopamine; Fungicides, Industrial; Herbicides; Immunohistochemistry; Levodopa; Male; Maneb; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Paraquat; Parkinson Disease, Secondary; Phytotherapy; Plant Roots; Polygonum; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
Chemical genomic profiling for identifying intracellular targets of toxicants producing Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Cluster Analysis; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Fungal; Genome, Human; Humans; Insecticides; Oligonucleotide Array Sequence Analysis; Paraquat; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Proteins; Saccharomyces cerevisiae; Sequence Homology, Nucleic Acid; Ubiquitin | 2007 |
Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Administration, Inhalation; Administration, Intranasal; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Administration Schedule; Herbicides; Insecticides; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Degeneration; Neurons; Paraquat; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra | 2007 |
Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain.
Topics: Administration, Oral; Animals; Brain; Disease Models, Animal; Half-Life; Herbicides; Injections, Intramuscular; Lipid Peroxidation; Male; Mice; Paraquat; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex | 2007 |
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Cell Death; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Herbicides; Male; Mice; Mice, Inbred C57BL; Nerve Endings; Nervous System; Neurons; Paraquat; Parkinson Disease, Secondary; Substantia Nigra; Synaptic Transmission | 1999 |
The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Carrier Proteins; Cell Count; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Administration Schedule; Drug Synergism; Glial Fibrillary Acidic Protein; Gliosis; Injections, Intraperitoneal; Lung; Male; Maneb; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Tissue Proteins; Nucleus Accumbens; Paraquat; Parkinson Disease, Secondary; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2000 |
Parkinson disease in farm workers.
Topics: Agriculture; Humans; Male; Middle Aged; Occupational Diseases; Paraquat; Parkinson Disease, Secondary | 1989 |
[No Parkinsonian syndrome following acute paraquat poisoning].
Topics: Accidents; Antipsychotic Agents; Athetosis; Chorea; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Paraquat; Parkinson Disease, Secondary; Suicide, Attempted | 1988 |
Paraquat and Parkinson's disease.
Topics: Adult; Humans; Male; Oxidation-Reduction; Paraquat; Parkinson Disease, Secondary | 1987 |
Paraquat and Parkinson's disease.
Topics: Agricultural Workers' Diseases; Humans; Paraquat; Parkinson Disease, Secondary; Pesticides; Saskatchewan | 1987 |
Paraquat and Parkinson's disease.
Topics: Humans; Paraquat; Parkinson Disease, Secondary | 1986 |
Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Drug Interactions; Epinephrine; Melanophores; Motor Activity; Norepinephrine; Paraquat; Pargyline; Parkinson Disease, Secondary; Pigmentation; Posture; Pyridines; Pyridinium Compounds; Rana pipiens; Reflex | 1985 |